Cosopt and Oxaliplatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cosopt (dorzolamide hydrochloride; timolol maleate) and Oxaliplatin (oxaliplatin). Common drug interactions include diarrhoea among females and cardio-respiratory arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Cosopt and Oxaliplatin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Cosopt?

Cosopt has active ingredients of dorzolamide hydrochloride; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 9,029 Cosopt users. Check the latest studies of Cosopt.

What is Oxaliplatin?

Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.



On Jul, 11, 2026

19 people who take Cosopt and Oxaliplatin together, and have interactions are studied.

Cosopt and Oxaliplatin drug interactions.

What are the common drug interactions of Cosopt and Oxaliplatin, by gender? *:

female:

  1. Diarrhoea
  2. Sudden death
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Cardiac arrest
  5. Dehydration (dryness resulting from the removal of water)
  6. Hot flush (sudden feelings of heat)
  7. Leukocytosis (increased white blood cells)
  8. Mucosal inflammation (infection of mucous membrane)
  9. Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)
  10. Thrombocytopenia (decrease of platelets in blood)

male:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Hepatic failure (liver failure)
  3. Gastric cancer stage iv (cancer cells have spread to distant organs)
  4. Metastatic gastric cancer (cancer types can spread to the stomach from other place)
  5. Hyperglycaemia (high blood sugar)
  6. Metastases to lymph nodes (cancer spreads to lymph node)
  7. Asthenia (weakness)
  8. Dehydration (dryness resulting from the removal of water)
  9. Diabetes mellitus inadequate control
  10. Gastric cancer (stomach cancer)

What are the common drug interactions of Cosopt and Oxaliplatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Hepatic failure (liver failure)
  3. Metastatic gastric cancer (cancer types can spread to the stomach from other place)
  4. Metastases to lymph nodes (cancer spreads to lymph node)
  5. Gastric cancer (stomach cancer)
  6. Gastric cancer stage ii (the tumour has penetrated the outer layer of the stomach. cancer cells have not spread to lymph nodes or other organs)
  7. Gastric cancer stage iv (cancer cells have spread to distant organs)

60+:

  1. Diarrhoea
  2. Sudden death
  3. Chills (felling of cold)
  4. Cough
  5. Death
  6. Decreased appetite
  7. Dyspnoea (difficult or laboured respiration)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Infection
  10. Malignant neoplasm progression (cancer tumour came back)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.79%
  2. Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 10.53%
  3. Pancreatic Insufficiency: 2 people, 10.53%
  4. Pancreatic Carcinoma (pancreatic cancer): 2 people, 10.53%
  5. Oedema (fluid collection in tissue): 2 people, 10.53%
  6. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 10.53%
  7. Intracardiac Thrombus (presence of a circumscribed mass with heart wall): 2 people, 10.53%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.53%
  9. High Blood Pressure: 2 people, 10.53%
  10. Diabetes: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Cosopt and Oxaliplatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cosopt and Oxaliplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cosopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxaliplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cosopt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxaliplatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dorzolamide hydrochloride; timolol maleate and oxaliplatin (the active ingredients of Cosopt and Oxaliplatin, respectively), and Cosopt and Oxaliplatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: